Vincke C - Search Results

1

Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33.

Romão E, Krasniqi A, Maes L, Vandenbrande C, Sterckx YG, Stijlemans B, Vincke C, Devoogdt N, Muyldermans S. Romão E, et al. Among authors: vincke c. Int J Mol Sci. 2020 Jan 2;21(1):310. doi: 10.3390/ijms21010310. Int J Mol Sci. 2020. PMID: 31906437 Free PMC article.

2

Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH.

Conrath K, Vincke C, Stijlemans B, Schymkowitz J, Decanniere K, Wyns L, Muyldermans S, Loris R. Conrath K, et al. Among authors: vincke c. J Mol Biol. 2005 Jul 1;350(1):112-25. doi: 10.1016/j.jmb.2005.04.050. J Mol Biol. 2005. PMID: 15913651

3

General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold.

Vincke C, Loris R, Saerens D, Martinez-Rodriguez S, Muyldermans S, Conrath K. Vincke C, et al. J Biol Chem. 2009 Jan 30;284(5):3273-3284. doi: 10.1074/jbc.M806889200. Epub 2008 Nov 14. J Biol Chem. 2009. PMID: 19010777 Free article.

4

Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom.

Abderrazek RB, Hmila I, Vincke C, Benlasfar Z, Pellis M, Dabbek H, Saerens D, El Ayeb M, Muyldermans S, Bouhaouala-Zahar B. Abderrazek RB, et al. Among authors: vincke c. Biochem J. 2009 Nov 11;424(2):263-72. doi: 10.1042/BJ20090697. Biochem J. 2009. PMID: 19732033

5

A novel promiscuous class of camelid single-domain antibody contributes to the antigen-binding repertoire.

Deschacht N, De Groeve K, Vincke C, Raes G, De Baetselier P, Muyldermans S. Deschacht N, et al. Among authors: vincke c. J Immunol. 2010 May 15;184(10):5696-704. doi: 10.4049/jimmunol.0903722. Epub 2010 Apr 19. J Immunol. 2010. PMID: 20404276

6

In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.

Vaneycken I, Govaert J, Vincke C, Caveliers V, Lahoutte T, De Baetselier P, Raes G, Bossuyt A, Muyldermans S, Devoogdt N. Vaneycken I, et al. Among authors: vincke c. J Nucl Med. 2010 Jul;51(7):1099-106. doi: 10.2967/jnumed.109.069823. Epub 2010 Jun 16. J Nucl Med. 2010. PMID: 20554727 Free article.

7

Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.

Vaneycken I, Devoogdt N, Van Gassen N, Vincke C, Xavier C, Wernery U, Muyldermans S, Lahoutte T, Caveliers V. Vaneycken I, et al. Among authors: vincke c. FASEB J. 2011 Jul;25(7):2433-46. doi: 10.1096/fj.10-180331. Epub 2011 Apr 8. FASEB J. 2011. PMID: 21478264

8

Dual beneficial effect of interloop disulfide bond for single domain antibody fragments.

Govaert J, Pellis M, Deschacht N, Vincke C, Conrath K, Muyldermans S, Saerens D. Govaert J, et al. Among authors: vincke c. J Biol Chem. 2012 Jan 13;287(3):1970-9. doi: 10.1074/jbc.M111.242818. Epub 2011 Nov 29. J Biol Chem. 2012. PMID: 22128183 Free PMC article.

9

A bacterial-two-hybrid selection system for one-step isolation of intracellularly functional Nanobodies.

Pellis M, Pardon E, Zolghadr K, Rothbauer U, Vincke C, Kinne J, Dierynck I, Hertogs K, Leonhardt H, Messens J, Muyldermans S, Conrath K. Pellis M, et al. Among authors: vincke c. Arch Biochem Biophys. 2012 Oct 15;526(2):114-23. doi: 10.1016/j.abb.2012.04.023. Epub 2012 May 11. Arch Biochem Biophys. 2012. PMID: 22583807

10

Introduction to heavy chain antibodies and derived Nanobodies.

Vincke C, Muyldermans S. Vincke C, et al. Methods Mol Biol. 2012;911:15-26. doi: 10.1007/978-1-61779-968-6_2. Methods Mol Biol. 2012. PMID: 22886243 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters